124 related articles for article (PubMed ID: 29953513)
21. Nanomechanical Signatures in Glioma Cells Depend on CD44 Distribution in IDH1 Wild-Type but Not in IDH1R132H Mutant Early-Passage Cultures.
Shmelev ME; Farniev VM; Shved NA; Kumeiko VV
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835465
[TBL] [Abstract][Full Text] [Related]
22. Gene of the month:
Bruce-Brand C; Govender D
J Clin Pathol; 2020 Oct; 73(10):611-615. PubMed ID: 32727816
[No Abstract] [Full Text] [Related]
23. Current biomarker-associated procedures of cancer modeling-a reference in the context of IDH1 mutant glioma.
Mehrjardi NZ; Hänggi D; Kahlert UD
Cell Death Dis; 2020 Nov; 11(11):998. PubMed ID: 33221817
[TBL] [Abstract][Full Text] [Related]
24. IDH1R132H in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis.
Rosiak K; Smolarz M; Stec WJ; Peciak J; Grzela D; Winiecka-Klimek M; Stoczynska-Fidelus E; Krynska B; Piaskowski S; Rieske P
PLoS One; 2016; 11(5):e0154726. PubMed ID: 27145078
[TBL] [Abstract][Full Text] [Related]
25. An activating germline
Blackburn PR; Carter JM; Oglesbee D; Westendorf JJ; Neff BA; Stichel D; Tsen DW; Gavrilova RH; Wesseling P; von Deimling A; Caulfield TR; Klee EW; Pusch S; Inwards CY
HGG Adv; 2020 Oct; 1(1):100006. PubMed ID: 35047830
[TBL] [Abstract][Full Text] [Related]
26. Vulnerability of IDH1-Mutant Cancers to Histone Deacetylase Inhibition via Orthogonal Suppression of DNA Repair.
Dow J; Krysztofiak A; Liu Y; Colon-Rios DA; Rogers FA; Glazer PM
Mol Cancer Res; 2021 Dec; 19(12):2057-2067. PubMed ID: 34535560
[TBL] [Abstract][Full Text] [Related]
27. Oncometabolite D-2-hydroxyglutarate-dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia.
Zhu X; Hao J; Zhang H; Chi M; Wang Y; Huang J; Xu R; Xincai Z; Xin B; Sun X; Zhang J; Zhou S; Cheng D; Yuan T; Ding J; Zheng S; Guo C; Yang Q
Commun Biol; 2023 Sep; 6(1):977. PubMed ID: 37741882
[TBL] [Abstract][Full Text] [Related]
28. The IDH1 inhibitor ivosidenib improved seizures in a patient with drug-resistant epilepsy from IDH1 mutant oligodendroglioma.
Vo AH; Ambady P; Spencer D
Epilepsy Behav Rep; 2022; 18():100526. PubMed ID: 35198955
[TBL] [Abstract][Full Text] [Related]
29. Single-cell profiling of D-2-hydroxyglutarate using surface-immobilized resazurin analogs.
Cheng H; Li Z; Guo Z; Shao S; Mo L; Wei W; Xue M
Biosens Bioelectron; 2021 Oct; 190():113368. PubMed ID: 34098361
[TBL] [Abstract][Full Text] [Related]
30. Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.
Luo J; Liu P; Lu C; Bian W; Su D; Zhu C; Xie S; Pan Y; Li N; Cui W; Pei DS; Yang X
Brain; 2021 Mar; 144(2):615-635. PubMed ID: 33279959
[TBL] [Abstract][Full Text] [Related]
31. Building the vertebrate codex using the gene breaking protein trap library.
Ichino N; Serres MR; Urban RM; Urban MD; Treichel AJ; Schaefbauer KJ; Tallant LE; Varshney GK; Skuster KJ; McNulty MS; Daby CL; Wang Y; Liao HK; El-Rass S; Ding Y; Liu W; Anderson JL; Wishman MD; Sabharwal A; Schimmenti LA; Sivasubbu S; Balciunas D; Hammerschmidt M; Farber SA; Wen XY; Xu X; McGrail M; Essner JJ; Burgess SM; Clark KJ; Ekker SC
Elife; 2020 Aug; 9():. PubMed ID: 32779569
[TBL] [Abstract][Full Text] [Related]
32. Metabolic Landscape of a Genetically Engineered Mouse Model of IDH1 Mutant Glioma.
Ruiz-Rodado V; Seki T; Dowdy T; Lita A; Zhang M; Han S; Yang C; Cherukuri MK; Gilbert MR; Larion M
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575619
[TBL] [Abstract][Full Text] [Related]
33. Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanisms.
Mealka M; Sierra NA; Avellaneda Matteo D; Albekioni E; Khoury R; Mai T; Conley BM; Coleman NJ; Sabo KA; Komives EA; Bobkov AA; Cooksy AL; Silletti S; Schiffer JM; Huxford T; Sohl CD
Nat Commun; 2024 May; 15(1):3785. PubMed ID: 38710674
[TBL] [Abstract][Full Text] [Related]
34. IDH-mutant glioma: A new IDH1 inhibitor moves forward.
Miller JJ; Arrillaga-Romany I
Neuro Oncol; 2023 Feb; 25(2):337-338. PubMed ID: 36526609
[No Abstract] [Full Text] [Related]
35. Non-Invasive Measurement of Drug and 2-HG Signals Using
Wenger KJ; Richter C; Burger MC; Urban H; Kaulfuss S; Harter PN; Sreeramulu S; Schwalbe H; Steinbach JP; Hattingen E; Bähr O; Pilatus U
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33138036
[TBL] [Abstract][Full Text] [Related]
36. Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
Zhao Q
Biochem Biophys Res Commun; 2022 Dec; 637():254-258. PubMed ID: 36410274
[TBL] [Abstract][Full Text] [Related]
37. Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype.
Cejalvo T; Gargini R; Segura-Collar B; Mata-Martínez P; Herranz B; Cantero D; Ruano Y; García-Pérez D; Pérez-Núñez Á; Ramos A; Hernández-Laín A; Martín-Soberón MC; Sánchez-Gómez P; Sepúlveda-Sánchez JM
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33147752
[TBL] [Abstract][Full Text] [Related]
38. A comparison of behavioral and reproductive parameters between wild-type, transgenic and mutant zebrafish: Could they all be considered the same "zebrafish" for reglementary assays on endocrine disruption?
De Oliveira J; Chadili E; Turies C; Brion F; Cousin X; Hinfray N
Comp Biochem Physiol C Toxicol Pharmacol; 2021 Jan; 239():108879. PubMed ID: 32877737
[TBL] [Abstract][Full Text] [Related]
39. Analysis of transgenic zebrafish expressing the Lenz-Majewski syndrome gene
Seda M; Peskett E; Demetriou C; Bryant D; Moore GE; Stanier P; Jenkins D
F1000Res; 2019; 8():273. PubMed ID: 31231513
[No Abstract] [Full Text] [Related]
40. Modeling Human Muscular Dystrophies in Zebrafish: Mutant Lines, Transgenic Fluorescent Biosensors, and Phenotyping Assays.
Tesoriero C; Greco F; Cannone E; Ghirotto F; Facchinello N; Schiavone M; Vettori A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
